422
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Pulmonary hypertension in pediatrics. A feasible approach to bridge the gap between real world and guidelines

, , , , , & show all
Pages 3820-3826 | Received 16 Nov 2019, Accepted 18 Nov 2019, Published online: 02 Dec 2019

References

  • Galiè N, Humbert M, Vachiery JL, et al. ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
  • Hill KD, Lim DS, Everett AD, et al. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. Cathet Cardiovasc Intervent. 2010;76(6):865–873.
  • Barst RJ, McGoon MD, Elliott CG, et al. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012;125(1):113–122.
  • Berger RM, Beghetti M, Humpl T, et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet. 2012;379(9815):537–546.
  • van Loon RL, Roofthooft MT, Hillege HL, et al. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation. 2011;124(16):1755–1764.
  • Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK pulmonary hypertension service for children 2001–2006. Heart. 2008;95(4):312–317.
  • Fraisse A, Jais X, Schleich JM, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. 2010;103(2):66–74.
  • Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med. 2010;11(Suppl 2):S79–S84.
  • Abman SH, Hansmann G, Archer SL, et al. American Heart Association Council on cardiopulmonary. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037–2099.
  • Iacovidou N, Syggelou A, Fanos V, et al. The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature. CPD. 2012;18(21):3034–3045.
  • Simonneau G, Gatzoulis MA, Adatia I, et al. Updated Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25):D34–D41.
  • del Cerro MJ, Abman S, Diaz G, et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric TaskForce, Panama 2011. Pulm Circ. 2011;1(2):286–298.
  • Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J. 2019;53(1):1801916.
  • Calcaterra G, Fanos V, Bassareo PP. Still puzzling about a clear definition of pulmonary arterial hypertension in newborns. Eur Respir J. 2019;53(3):1900005.
  • Palma G, Giordano R, Russolillo V, et al. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery. Tex Heart Inst J. 2011;38(3):238–242.
  • Bassareo PP, Neroni P, Montis S, et al. Morgagni’s diaphragmatic hernia mimicking a severe congenital heart disease in a newborn: a case report. J Med Case Rep. 2010;4:395.
  • Haworth SG. Idiopathic pulmonary arterial hypertension in childhood. Cardiol Rev. 2010;18(2):64–66.
  • Lammers AE, Burch M, Benden C, et al. Lung transplantation in children with idiopathic pulmonary arterial hypertension. Pediatr Pulmonol. 2010;45(3):263–269.
  • Bush D, Galambos C, Ivy DD, et al. Clinical characteristics and risk factors for developing pulmonary hypertension in children with Down syndrome. J Pediatr. 2018;202:212–219.e2.
  • Ong MS, Abman S, Austin ED, et al. Racial and ethnic differences in pediatric pulmonary hypertension: an analysis of the pediatric pulmonary hypertension network registry. J Pediatr. 2019;211:63–71.e6.
  • Galiè N, Simonneau G. The fifth world symposium on pulmonary hypertension. J Am Coll Cardiol. 2013;62(25):D1–D3.
  • Rosenzweig EB, Abman SH, Berger R. Response: still puzzling about a clear definition of pulmonary arterial hypertension in newborns. Eur Respir J. 2019;53(3):1900135.
  • Beck EM, Hatton ND, Ryan JJ. Novel techniques for advancing our understanding of pulmonary arterial hypertension. Eur Respir J. 2019;53(5):1900556.
  • Gibbs JSR, Torbicki A. Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks? Eur Respir J. 2019;53(3):1900197.
  • Cascino TM, McLaughlin VV, Richardson CR, et al. Physical activity and quality of life in patients with pulmonary hypertension. Eur Respir J. 2019;53(6):1900028.
  • Shaughnessy AF, Vaswani A, Andrews BK, et al. Developing a clinician friendly tool to identify useful clinical practice guidelines: G-TRUST. Ann Fam Med. 2017;15(5):413–418.
  • Galiè N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1801889.
  • Nakwan N, Jain S, Kumar K, et al. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome. J Matern Fetal Neonatal Med. 2018;1–6.
  • Beghetti M, Brand M, Berger RMF, et al. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: an analysis of the TOPP registry. Int J Cardiol. 2019;289:110–115.
  • AbdelMassih AF, Al. Zahraa Hassan F, El-Gammal A, et al. The overlooked left ventricle in persistent pulmonary hypertension of the newborn. J Matern Fetal Neonatal Med. 2019;1–5.
  • Seth SA, Soraisham AS, Harabor A. Risk factors and outcomes of early pulmonary hypertension in preterm infants. J Matern Fetal Neonatal Med. 2018;31(23):3147–3152.
  • Hansmann G, Koestenberger M, Alastalo TP, et al. 2019. Updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38(9):879–901.
  • del Cerro Marín MJ, Sabaté Rotés A, Rodriguez Ogando A, et al. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry. Am J Respir Crit Care Med. 2014;190(12):1421–1429.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.